Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Garenoxacin

Garenoxacin

Garenoxacin structure

Garenoxacin 

structure
  • CAS No:

    194804-75-6

  • Formula:

    C23H20F2N2O4

  • Chemical Name:

    Garenoxacin

  • Synonyms:

    3-Quinolinecarboxylic acid,1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-;3-Quinolinecarboxylic acid,1-cyclopropyl-8-(difluoromethoxy)-7-(2,3-dihydro-1-methyl-1H-isoindol-5-yl)-1,4-dihydro-4-oxo-,(+)-;1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid;Garenoxacin;T 3811;Ganefloxacin;Garenfloxacin;(R)-1-Cyclopropyl-8-(difluoromethoxy)-7-(1-methylisoindolin-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;345632-74-8

  • Categories:

    Active Pharmaceutical Ingredients  >  Synthetic Anti-infective Drugs

Description

ChEBI: A quinolinemonocarboxylic acid that is 1,4-dihydroquinoline-3-carboxylic acid that is substituted by a cyclopropyl group at position 1, an oxo group at position 4, a (1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl group at po ition 7, and a difluoromethoxy group at position 8.Garenoxacin is a new quinolone antimicrobial agent that exhibits a broad spectrum of activity against both Gram-negative and Gram-positive organisms, including the important community-acquired respiratory pathogens S


Garenoxacin is a quinolinemonocarboxylic acid that is 1,4-dihydroquinoline-3-carboxylic acid that is substituted by a cyclopropyl group at position 1, an oxo group at position 4, a (1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl group at position 7, and a difluoromethoxy group at position 8. It has a role as an antibacterial drug and a non-steroidal anti-inflammatory drug. It is a quinolone antibiotic, a quinolinemonocarboxylic acid, an organofluorine compound, a member of cyclopropanes, an aromatic ether and a member of isoindoles.|Garenoxacin, a quinolone antibiotic, is being investigated for the treatment of gram-positive and gram-negative bacterial infections.

Garenoxacin Basic Attributes

426.41

426.41

V72H9867WB

DTXSID30173135

J - Antiinfectives for systemic use

Characteristics

78.9

2.28

1.421±0.06 g/cm3(Predicted)

226-227°; mp 234-235°

581.5±50.0 °C(Predicted)

305.5±30.1 °C

1.631

D27 -9.0° (c = 0.10 in N,N-dimethylformamide)

Drug Information

Investigated for use/treatment in bacterial infection.

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)|Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)

BMS 284756

Garenoxacin Use and Manufacturing

Des-F(6)-quinolone antibacterial; topoisomerase II inhibitor. Antibacterial.

Computed Properties

Molecular Weight:426.4
XLogP3:2.1
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:8
Rotatable Bond Count:5
Exact Mass:426.13911345
Monoisotopic Mass:426.13911345
Topological Polar Surface Area:78.9
Heavy Atom Count:31
Complexity:771
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Garenoxacin

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.